Follow The Filings

BLCO Bausch Plus Lomb Corporation

Health Care, filed as BAUSCH PLUS LOMB CORP (COMMON SHARES), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 5 Owners
  • Max 0.8%
  • $200M
  • 1 new 1 add 2 small

In 2026 Q2 Dan Loeb opened a position in Bausch Plus Lomb, and Davidson Kempner Capital Management added.

Who owns this now

Largest portfolio weights among holders, up to 0.8% (Howard Marks, Oaktree Capital Management). Not free-float ownership.

  1. Howard Marks Add 0.79%
  2. Carl Icahn 0.70%
  3. Davidson Kempner Capital Mana... Add 0.62%
  4. Glenview Capital Management Add 0.58%
  5. Dan Loeb New 0.03%

Who owns BLCO

Sorted by value, long equity only, as of 2026 Q2.

History
Carl Icahn, Icahn Capital 0.70% Hold 3,500,000 $58M History
Howard Marks, Oaktree Capital Management 0.79% Small add +1.7% 3,441,042 $57M History
Davidson Kempner Capital Management 0.62%, was 0.48% Add +43.6% 3,158,972 $52M History
Glenview Capital Management 0.58% Small add +0.4% 1,918,148 $32M History
Dan Loeb, Third Point 0.03% New 0.03% 85,000 $1.4M History

5 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by BLCO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BLCO insider trades
  • $1.2M bought by 9 insiders
  • $1.2M sold by 2 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Frederick Munsch SVP, Controller and CAO
    Sale
    $888K 52,900 shares at $16.78 54% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  2. Andrew C. Von Eschenbach Director
    Sale
    $307K 18,559 shares at $16.53 23% of stake
    Traded Aug 6–7 Filed Aug 10
    ↗
  3. A Robert D Bailey EVP & Chief Legal Officer
    Buy
    $250K 14,600 shares at $17.15 +6.7% to stake
    Traded Mar 6 Filed Mar 10
    ↗
  4. Sam Eldessouky CFO
    Buy
    $69K 4,000 shares at $17.13 +1% to stake
    Traded Mar 6 Filed Mar 10
    ↗
  5. Brent L Saunders CEO
    Buy
    $252K 14,700 shares at $17.14 +1.5% to stake
    Traded Mar 6 Filed Mar 10
    ↗
  6. Thomas W. Ross Sr. Director
    Buy
    $80K 4,500 shares at $17.68 +7.5% to stake
    Traded Mar 3 Filed Mar 4
    ↗
  7. Eduardo Alfonso Director
    Buy
    $77K 4,300 shares at $17.90 +82% to stake
    Traded Mar 2 Filed Mar 3
    ↗
  8. Andrew C. Von Eschenbach Director
    Buy
    $80K 4,364 shares at $18.31 +7% to stake
    Traded Feb 27 Filed Mar 3
    ↗
  9. Steven H Collis Director
    Buy
    $267K 15,000 shares at $17.81 +285% to stake
    Traded Feb 23 Filed Feb 24
    ↗
  10. Russel C Robertson Director
    Buy
    $79K 4,400 shares at $17.90 +6.5% to stake
    Traded Feb 20 Filed Feb 24
    ↗
  11. Karen Ling Director
    Buy
    $71K 4,000 shares at $17.74 +11% to stake
    Traded Feb 19 Filed Feb 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 49 stock grants and 28 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 9 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K/A 5.02 Filing Doc
8-K 1.01,5.02,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $4.15B $4.79B $5.1B
Net income -$260M -$317M -$360M
Net margin * -6.3% -6.6% -7.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $2.74B $2.79B $2.98B
Total non-current assets * $10.7B $10.68B $11.04B
Total assets $13.44B $13.47B $14.02B
Total current liabilities $1.58B $1.74B $1.92B
Total non-current liabilities * $4.94B $5.19B $5.58B
Total equity $6.85B $6.47B $6.45B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$17M $232M $283M
Cash from investing -$2.11B -$0.412B -$0.455B
Cash from financing $2.08B $0.178B $0.225B
Net change in cash -$46M -$18M $81M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.